NCT06955715
Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 6 words Show 7 more changesShow less
- Primary endpoints: details revised at 2 of 2 entries
- Trial completed
- Final enrollment: 4 participants (planned 10)
- Primary completion date changed from estimate of May 1, 2026 to Nov 18, 2025
- Study completion date changed from estimate of Dec 31, 2026 to Sep 21, 2026
- Study description revised
- Site details revised
- Notable Eligibility criteria revised
- Study description expanded, about 3 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Frequency of PDHM provision (#/day)
Timeframe: 8-12 week intervention period
Volume of PDHM provision (mL/day)
Timeframe: 8-12 week intervention period
Secondary (2)
Events of infant intolerance (n, %)
Caregiver-related experiences and challenges
Arms and interventions
Pasteurized Donor Human MilkExperimental
Pasteurized donor human milk sourced from the Norther Star Mother's Milk Bank (Calgary, AB, Canada)
Other: Pasteurized Donor Human Milk
Sites
1 site in 1 country
- University of SaskatchewanSaskatoon, Saskatchewan, Canada